Evidence map›Paper›PMID 41155260›Full record

ArticleInternational journal of molecular sciences2025

Are Advanced Glycation End-Products and Skin Autofluorescence Associated with E-Selectin and Pulse Wave Velocity as Markers of Atherosclerosis Risk in Children with Obesity?

Anna Medyńska, Anna Noczyńska, Danuta Zwolińska

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Anna MedyńskaDepartment and Clinic of Pediatric Nephrology, Medical University of Wrocław, 50-367 Wrocław, Poland.
Anna NoczyńskaDepartment and Clinic of Pediatrics, Endocrinology, Diabetology and Metabolic Diseases, Medical University of Wrocław, 50-367 Wrocław, Poland.
Danuta ZwolińskaDepartment and Clinic of Pediatric Nephrology, Medical University of Wrocław, 50-367 Wrocław, Poland.

Funding

Wroclaw Medical University, Poland grant number ST-C210.16.082
6 · The paper itself

Abstract

Obesity is a risk factor for numerous complications, including atherosclerosis, the pathogenesis of which is complex. The aim of our study is to evaluate serum levels of E-selectin and hs-CRP and pulse wave velocity (PWV) as atherosclerosis risk factors and to explore their relationship with advanced glycation end products (AGEs), methylgioxal (MG) and skin autofluorescence (sAF). We evaluated 125 children aged 8-18 years with simple obesity, stratified into two subgroups based on SDS BMI (Group I: 2-4; Group II: >4), and compared them with 33 age-matched peers of normal weight. Children with obesity exhibited significantly elevated serum concentrations of AGEs, MG, E-selectin, and hs-CRP relative to the control group. Additionally, both height-normalized pulse wave velocity (SDS PWV) and sAF values were significantly higher in the children with obesity compared to their normal-weight counterparts. Except for sAF, which was elevated in children with obesity with a higher SDS BMI, no significant differences were observed among the subgroups of children. Positive correlations were observed between E-selectin and AGEs, MG and SDS PWV, as well as sAF and SDS BMI. Our findings indicate that children with obesity exhibit early signs of atherosclerotic changes, regardless of the degree of obesity. Moreover, circulating AGEs may represent a more reliable biomarker of atherosclerosis risk than sAF, as suggested by the strong positive correlation between AGEs and E-selectin. Further studies are warranted to validate these findings.

Indexed as

AtherosclerosisE-SelectinGlycation End Products, AdvancedObesityPediatric ObesitySkinAdolescentBiomarkersBody Mass IndexChildFemaleHumansMalePulse Wave AnalysisRisk FactorsBiomarkersE-SelectinGlycation End Products, Advancedadvances glication end products (AGEs)atherosclerosischildrenobesityskin autofluorescens (sAF)

Identifiers

PMID41155260
PMCPMC12563969

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.